Keyword Analysis & Research: zmapp

Keyword Analysis


Keyword CPC PCC Volume Score Length of keyword
zmapp0.240.31571505

Keyword Research: People who searched zmapp also searched

Keyword CPC PCC Volume Score
zmapp0.640.4742058
zmapping0.070.7359166
zmapp ebola0.70.575492
smappen1.210.5853323
mappy1.990.9713332
zmapp production0.31889869
zmapp drug0.810.8183143
smapply.net0.680.515216
zmapping 3d model0.80.4556680
zappos1.180.9229138
zmapplus0.431961533
zmapp fda1.620.1699364

Search Results related to zmapp on Search Engine

  • ZMapp - Wikipedia

    wikipedia.org

    https://en.wikipedia.org/wiki/ZMapp

    WEBZMapp is an experimental biopharmaceutical drug comprising three chimeric monoclonal antibodies under development as a treatment for Ebola virus disease.

    DA: 59 PA: 53 MOZ Rank: 25

  • Study finds Ebola treatment ZMapp holds promise, although …

    nih.gov

    https://www.nih.gov/news-events/news-releases/study-finds-ebola-treatment-zmapp-holds-promise-although-results-not-definitive

    WEBOct 13, 2016 · ZMapp, developed by Mapp Biopharmaceutical, Inc., based in San Diego, is composed of three different laboratory-made proteins called monoclonal antibodies. The treatment is designed to prevent the progression of EVD within the body by targeting the main surface protein of the Ebola virus.

    DA: 11 PA: 84 MOZ Rank: 88

  • ZMapp® FAQ - Mapp Biopharmaceutical, Inc.

    mappbio.com

    https://mappbio.com/zmapp-faq/

    WEBOct 27, 2022 · ZMapp® is an experimental new therapy that is being developed to treat patients with Ebola. It is comprised of a series of three different monoclonal antibodies that work to prevent the spread of the disease within the body. Who developed ZMapp®? How is ZMapp® administered? What are the potential side effects?

    DA: 97 PA: 76 MOZ Rank: 62

  • A Randomized, Controlled Trial of ZMapp for Ebola Virus …

    nejm.org

    https://www.nejm.org/doi/pdf/10.1056/NEJMoa1604330

    WEBOct 13, 2016 · Data from studies in nonhuman primates suggest that the triple monoclonal anti-body cocktail ZMapp is a promising immune-based treatment for Ebola virus disease (EVD). METHODS.

    DA: 81 PA: 84 MOZ Rank: 94

  • FDA Approves First Treatment for Ebola Virus | FDA - U.S. Food …

    fda.gov

    https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-ebola-virus

    WEBOctober 14, 2020. Today, the U.S. Food and Drug Administration approved Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn), a mixture of three monoclonal antibodies, as the first FDA-approved...

    DA: 27 PA: 19 MOZ Rank: 36

  • ZMapp: The Experimental Ebola Treatment Explained

    popsci.com

    https://www.popsci.com/article/science/zmapp-experimental-ebola-treatment-explained/

    WEBAug 9, 2014 · ZMapp itself is made up of proteins called monoclonal antibodies, which bind to the Ebola virus rendering it harmless. The drug is made by infecting mice with a protein from the Ebola virus, and...

    DA: 93 PA: 60 MOZ Rank: 70

  • WHO makes new recommendations for Ebola treatments, calls …

    who.int

    https://www.who.int/news/item/19-08-2022-who-makes-new-recommendations-for-ebola-treatments-----calls-for-improved-access

    WEBAug 19, 2022 · There is also a recommendation on therapeutics that should not be used to treat patients: these include ZMapp and remdesivir. All these recommendations only apply to Ebola virus disease caused by Ebola virus (EBOV; Zaire ebolavirus). “Advances in supportive care and therapeutics over the past decade have revolutionized the treatment …

    DA: 11 PA: 70 MOZ Rank: 12

  • US signs contract with ZMapp maker to accelerate development of …

    bmj.com

    https://www.bmj.com/content/349/bmj.g5488

    WEBSep 4, 2014 · Michael McCarthy. Author affiliations. The US government has signed a multimillion dollar contract with the maker of the experimental Ebola drug ZMapp to accelerate the drug’s development. Under the contract the US Biomedical Advanced Research and Development Authority (BARDA) will provide funding, expertise, and …

    DA: 62 PA: 59 MOZ Rank: 78

  • ZMapp® - Mapp Biopharmaceutical, Inc.

    mappbio.com

    https://mappbio.com/z-mapp/

    WEBOct 27, 2022 · ZMapp® is composed of three “humanized” monoclonal antibodies manufactured in plants, specifically Nicotiana. It is an optimized cocktail combining the best components of MB‐003 (Mapp) and ZMAb (Defyrus/PHAC).

    DA: 100 PA: 14 MOZ Rank: 53

  • A Randomized, Controlled Trial of Ebola Virus Disease …

    nejm.org

    https://www.nejm.org/doi/pdf/10.1056/NEJMoa1910993

    WEBNov 27, 2019 · All patients received standard care and were randomly assigned in a 1:1:1:1 ratio to intravenous administration of the triple monoclonal antibody ZMapp (the control group), the antiviral agent...

    DA: 53 PA: 87 MOZ Rank: 72